GENETIC FACTORS INDUCING DISTURBED REGULATION OF ANGIOGENESIS IN DIABETES MELLITUS TYPE 2

GENETIC FACTORS INDUCING DISTURBED REGULATION OF ANGIOGENESIS IN DIABETES MELLITUS TYPE 2

Abstract. The article includes results of studying frequency distributions of polymorphic genotypes forsome genes regulating angiogenesis, i.e., MMP and VEGF, and their combinations with genotypes of some cytokines showing pro-angiogenic activity in patients with diabetes mellitus type 2 (DM2) and h...

Full description

Bibliographic Details
Main Authors:	V. I. Konenkov, A. V. Shevchenko, V. F. Prokof’ev, V. V. Klimontov, M. A. Korolev, O. N. Fazulina, S. A. Lapsina, E. A. Koroleva
Format:	Article
Language:	Russian
Published:	SPb RAACI 2014-07-01
Series:	Medicinskaâ Immunologiâ
Subjects:	matrix metalloproteinases vegf cytokines gene polymorphism diabetes mellitus type 2
Online Access:	https://www.mimmun.ru/mimmun/article/view/547

Similar Items

COMBINATIONS OF CYTOKINE AND MATRIX METALLOPROTEINASE GENES ASSOCIATED WITH RETINOPATHY IN TYPE 2 DIABETIC WOMEN
by: V. I. Konenkov, et al.
Published: (2015-12-01)

Combinations of cytokine and matrix metalloproteinase genes associated with retinopathy in type 2 diabetic women
by: V.I. Konenkov,, et al.
Published: (2013-04-01)

Genetic factors of angiogenic dysregulation in women with rheumatoid arthritis
by: V I Konenkov, et al.
Published: (2013-05-01)

Associations of vascular endothelial growth factor (VEGF) gene and cytokine (IL-1B, IL-4, IL-6, IL-10, TNFA) genes combinations with type 2 diabetes mellitus in women
by: Vladimir Iosifovich Konenkov, et al.
Published: (2012-09-01)

Matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis
by: A V Shevchenko, et al.
Published: (2015-12-01)

Cytokine gene polymorphism in type 2 diabetes mellitus in the Europeoid women of Russia
by: V I Konenkov, et al.
Published: (2012-10-01)

Analysis of genotypes combinations at the polymorphic points of the promoter regions of the genes of three matrix metalloproteinases and the gene of vascular endothelial growth factor (VEGF) in patients with prior acute myocardial infarction
by: A V Shevchenko, et al.
Published: (2014-04-01)

COMBINATION ANALYSIS OF CYTOKINE GENE PROMOTER POLYMORPHISMS OF IL1B T-31C, IL-6 G-174C, TNFA G-238A, TNFA G-308A, TNFA C-863A, IL4 C-590T, IL-10 C-592A FOR PREDICTION OF TREATMENT EFFICIENCY IN RHEUMATOID ARTHRITIS
by: V. I. Konenkov, et al.
Published: (2014-07-01)

Production of factors involved into fibrosis regulation by various types of human macrophages
by: A. A. Maksimova, et al.
Published: (2020-08-01)

Drynaria fortunei Promoted Angiogenesis Associated With Modified MMP-2/TIMP-2 Balance and Activation of VEGF Ligand/Receptors Expression
by: Sheng-Teng Huang, et al.
Published: (2018-09-01)

Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease
by: Alla Vladimirovna Shevchenko, et al.
Published: (2010-03-01)

Effects of growth factors and cytokins on soft tissue regeneration in patients with diabetes mellitus
by: Ekaterina Leonidovna Zaytseva, et al.
Published: (2014-03-01)

Polymorphism in the regulatory regions –С2578A and +C936T of the vascular endothelial growth factor (VEGF-A) gene in Russian women with rheumatoid arthritis
by: A V Shevchenko, et al.
Published: (2017-05-01)

Combinations of polymorphisms in the regulatory regions of cytokine genes are associated with diabetic retinopathy in type 2 diabetic patients
by: V. I. Konenkov, et al.
Published: (2018-01-01)

ASSOCIATION OF COMBINED GENOTYPE OF POLYMORPHIC CYTOKINE GENES SITES, ENDOTHELIAL GROWTH FACTOR AND METALLOPROTEASES WITH MYOCARDIAL INFARCTION DEVELOPMENT IN MEN
by: V. I. Konenkov, et al.
Published: (2014-10-01)

Some peculiarities of immunobiochemical disorders in pathogenesis of pseudoexfoliation syndrome
by: E.V. Egorova, et al.
Published: (2013-04-01)

POLYMORPHISMS OF EXTRACELLULAR CONNECTIVE TISSUE REMODELING PROTEINASES AND <i>MMP2, MMP3, MMP9</i> GENES, AND NEOANGIGENESIS <i>VEGF</i> GENE IN RETINAL MICROANGIOPATHY IN THE PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: A. V. Shevchenko, et al.
Published: (2019-07-01)

POLYMORPHISMS OF EXTRACELLULAR CONNECTIVE TISSUE REMODELING PROTEINASES AND MMP2, MMP3, MMP9 GENES, AND NEOANGIGENESIS VEGF GENE IN RETINAL MICROANGIOPATHY IN THE PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: Alla Vladimirovna Shevchenko, et al.
Published: (2019-03-01)

Polymorphic locus RS11568818 of the MMP7 gene is associated with the development of essеntial hypertension in women
by: M. I. Moskalenko, et al.
Published: (2018-11-01)

POSSIBILITIES OF USING THE GENOTYPING OF CYTOKINES WITH INFLAMMATION-REGULATORY ACTIVITY AS BIOLOGICAL MARKERS FOR PREDICTION OF THE EFFICIENCY OF THERAPY FOR RHEUMATOID ARTHRITIS
by: Vladimir Iosifovich Konenkov, et al.
Published: (2010-10-01)

Classification, regulation of activity, and genetic polymorphism of matrix metalloproteinases in health and disease
by: A. S. Shadrina, et al.
Published: (2017-08-01)

NETWORK APPROACH TO ANALYSIS OF QUANTITATIVE TRAIT LOCI FOR TUMOR NECROSIS FACTOR (TNFα-863, TNFα-308, TNFα-238), VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF-2578, VEGF+936) AND MATRIX METALLOPROTEINASE (ММР2-1306, ММР3-1171, ММР9-1569) GENES IN AGERELATED MACULAR DEGENERATION
by: A. V. Shevchenko, et al.
Published: (2017-10-01)

Relationship of matrix metalloproteinase-3 -11715A/6A polymorphism (rs35068180) and dilated cardiomyopathy
by: S. Yu. Nikulina, et al.
Published: (2020-11-01)

Associations between matrix metalloproteinase gene polymorphisms and glaucoma susceptibility: a meta-analysis
by: Ming-Yue Wu, et al.
Published: (2017-04-01)

Key VEGF signaling system components and matrix metalloproteinases in the diagnosis and prognosis of overall survival of patients with renal cell cancer
by: N. E. Kushlinskii, et al.
Published: (2020-07-01)

The role of obesity in the implementation of genetic predisposition to the development of essential hypertension in men
by: Maria I. Moskalenko, et al.
Published: (2020-03-01)

Comparative Serum Analyses Identify Cytokines and Hormones Commonly Dysregulated as Well as Implicated in Promoting Osteolysis in MMP-2-Deficient Mice and Children
by: Hassan Sarker, et al.
Published: (2020-09-01)

MMP1-1607 polymorphism increases the risk for periapical lesion development through the upregulation MMP-1 expression in association with pro-inflammatory milieu elements
by: Ana Paula Favaro TROMBONE, et al.

SOME PECULIARITIES OF IMMUNOBIOCHEMICAL DISORDERS IN PATHOGENESIS OF PSEUDOEXFOLIATION SYNDROME
by: E. V. Egorova, et al.
Published: (2015-12-01)

Terms of admission to the hospital and performing endovascular procedures in patients with acute myocardial infarction without ST segment elevation in real clinical practice
by: Ionatan R. Rafaeli, et al.
Published: (2020-11-01)

Association of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels with diabetic foot ulcer in Egyptians with type 2 diabetes mellitus
by: Ghada H Sayed, et al.
Published: (2018-01-01)

ANALYSIS OF ASSOCIATIONS OF VEGF-A GENE POLYMORPHISM AT POSITIONS 2578A/C AND +936C/T WITH DIFFERENT RECEPTOR STATUS IN BREAST CANCER PATIENTS
by: A. V. Shevchenko, et al.
Published: (2016-02-01)

Markers of connective tissue remodeling in genital prolapse
by: M L Khanzadian, et al.
Published: (2016-06-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

POLYMORPHISM OF VASCULAR ENDOTHELIAL GROWTH FACTOR REGIO PROMOTER C(-634)G AS A RISK FACTOR OF BALINESE TYPE-2 DIABETIC RETINOPATHY
by: A. A. Mas-Putrawati, et al.
Published: (2015-08-01)

Study of Matrix Metalloproteinase -1 Polymorphism and Susceptibility to Bladder Cancer
by: Delaram Nikfarjam, et al.
Published: (2017-12-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

ELISA study of matrix metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors of gastric cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2018-09-01)

Evaluation of metastatic potential of prostate cancer
by: Yoshitomo Chihara, et al.
Published: (2011-06-01)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

Cannot write session to /tmp/vufind_sessions/sess_4mr28m2e0m6g8fp20ac33cat9k